The McQuade Center for Strategic Research and Development, LLC (MSRD), established in the US by Japan-based Otsuka Pharm...
You have been working in plasmid research and production for 20 years and were immediately available wit...
On 4 January 2022, the Therapeutic Goods Administration (TGA) in Australia granted a further provisional determination t...
Ascletis Pharma Inc., based in China, has announced the expansion of the production of ritonavir oral tablets and oral d...
Yiling Pharmaceutical's depression-resolving and restlessness-relieving capsules have been approved for marketing via th...
Japan-based pharma firm Daiichi Sankyo Company has established wholly-owned subsidiaries in Australia (Daiichi Sankyo Au...
The Shimadzu 8th Global Pharma Summit 2021, the global flagship pharma event of Shimadzu was organized on...
Bushu Pharmaceuticals has agreed on an expanded partnership with Amgen Inc. and Amgen K.K. to provide its "Gateway to As...
From playing a central role in combatting COVID-19 to producing the small or individual batches required in personalized...
Christmas donation enables 20 women postdocs to join program for women scientists in managerial positions ...
American firm Johnson & Johnson (J&J) has announced its intent to separate the company’s Consumer Health b...
CPhI Worldwide – hosted in-person at Fiera Milano, Italy (9-11 November, 2021) – opened its doors to in...
Multiple regulatory filings have been submitted to expand distribution channels globally across China, Taiwan, South Kor...
KeyPlants is a leading international industry partner for standardized as well as customized process-integrated modular ...
And it’s happening on 16, 17 and 18 November from 13:00 - 16:30 hrs. SGT Your Time: 10:30 - 13:00 hrs. (Asia/Ca...
Otago University's School of Pharmacy in the Division of Health Sciences will be offering a Bachelor of Pharmaceutical S...
Today’s pharma manufacturers are finding they need more robust tools to meet modern regulatory expectations around...
Artificial Intelligence (AI) is a buzzword in the pharma industry with big firms announcing new projects in the field pr...
Japanese firm Daiichi Sankyo Company has launched DELYTACT® (teserpaturev/G47∆), an oncolytic virus developed ...
Japanese firm Takeda Pharmaceutical has announced the exercise of its option to acquire UK-based GammaDelta Therape...
On 25 Oct 2021, AstraZeneca’s A.Catalyst Network hosted its second Slush event, ‘Better Together? Evaluating...
Daiichi Sankyo has announced the progress of development of DS-5670, an mRNA vaccine in Japan, being evaluated against t...
CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing ph...
Phillips-Medisize, a US-based Molex company, has announced the expansion of its global manufacturing footprint, along wi...
Conversion to SE ("Societas Europaea") completed No impact on current business ...
